Get the Stockscreener App
67.14
0.06%
0.04
Pre-market:
66.90
-0.24
-0.36%
Solventum Corp stock is traded at $67.14, with a volume of 1.18M.
It is up +0.06% in the last 24 hours and down -8.79% over the past month.
Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.
See More
Previous Close:
$67.10
Open:
$66.73
24h Volume:
1.18M
Relative Volume:
1.06
Market Cap:
$11.65B
Revenue:
$8.35B
Net Income/Loss:
$1.56B
P/E Ratio:
7.5661
EPS:
8.8738
Net Cash Flow:
$-4.00M
1W Performance:
+1.54%
1M Performance:
-8.79%
6M Performance:
-8.93%
1Y Performance:
-12.02%
1-Day Range:
$66.67
$67.89
1-Week Range:
$66.17
$69.11
52-Week Range:
$60.70
$88.20
Solventum Corp Stock (SOLV) Company Profile
Name
Solventum Corp
Sector
Industry
Phone
651-733-1110
Address
C/O 3M COMPANY, ST. PAUL
Compare SOLV vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
67.14 | 11.65B | 8.35B | 1.56B | -4.00M | 8.8738 |
ISRG
Intuitive Surgical Inc
|
479.93 | 170.46B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
156.53 | 44.53B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
75.01 | 36.56B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
43.59 | 35.38B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
227.41 | 33.13B | 5.40B | 1.49B | 1.78B | 10.12 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-26-26 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-20-26 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Sep-11-25 | Initiated | Jefferies | Hold |
| Jul-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-01-25 | Upgrade | Argus | Hold → Buy |
| Jun-06-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-19-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Oct-08-24 | Initiated | Stifel | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Neutral |
| Sep-26-24 | Initiated | Wolfe Research | Peer Perform |
| Sep-05-24 | Initiated | BTIG Research | Neutral |
| Jun-24-24 | Initiated | Argus | Hold |
| May-30-24 | Initiated | Goldman | Sell |
| May-10-24 | Initiated | BofA Securities | Neutral |
| Apr-10-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-08-24 | Initiated | Wells Fargo | Equal Weight |
| Apr-02-24 | Initiated | Edward Jones | Hold |
View All
Solventum Corp Stock (SOLV) Latest News
SOLV SEC FilingsSolventum Corporation 10-K, 10-Q, 8-K Forms - Stock Titan
Solventum (SOLV) Q4 2025 adjusted diluted EPS reaches $1.57 on 3.5% organic sales growth - MSN
Jefferies reiterates Solventum stock rating citing margin upside - Investing.com
Here’s Why Adding Solventum Shares to Your Portfolio Makes Sense Right Now - Bitget
Here's Why You Should Hold Solventum Stock in Your Portfolio Now - Yahoo Finance
Solventum announces launch of secondary offering of common stock - MSN
Wells Fargo & Company Upgrades Solventum (NYSE:SOLV) to Hold - MarketBeat
Solventum Corporation $SOLV Shares Purchased by Davis Selected Advisers - MarketBeat
Solventum bolsters wound care portfolio with $850m Acera Surgical acquisition - MSN
UBS Maintains Solventum (SOLV) Neutral Recommendation - MSN
Curious about Solventum (SOLV) Q4 performance? Explore Wall Street estimates for key metrics - MSN
1 Healthcare Stock with Exciting Potential and 2 We Ignore - StockStory
Solventum Corp. stock rises Tuesday, outperforms market - MarketWatch
Solventum Corporation $SOLV Position Lifted by Clifford Capital Partners LLC - MarketBeat
Solventum (SOLV) Just Overtook the 200-Day Moving Average - MSN
Independent Franchise Partners LLP Has $941.65 Million Stock Position in Solventum Corporation $SOLV - MarketBeat
Korea Investment CORP Sells 40,000 Shares of Solventum Corporation $SOLV - MarketBeat
Solventum Corp. stock falls Thursday, underperforms market - MarketWatch
Barclays PLC Decreases Stock Holdings in Solventum Corporation $SOLV - MarketBeat
Top Solventum Insider Quietly Makes a Major Bullish Move - TipRanks
Investor Takes $14 Million Position in WEX as Fintech Firm Generates Record $2.7 Billion in Revenue - The Motley Fool
Solventum to Participate in the 2026 KeyBanc Healthcare Forum - GuruFocus
Insider Buying: Solventum (NYSE:SOLV) Director Buys 1,475 Shares of Stock - MarketBeat
Wendell Amy McBride buys Solventum (SOLV) shares worth $100k By Investing.com - Investing.com Nigeria
Wendell Amy McBride buys Solventum (SOLV) shares worth $100k - Investing.com
Director boosts Solventum (NYSE: SOLV) stake with 1,475-share open-market buy - Stock Titan
Intech Investment Management LLC Has $633,000 Stock Holdings in Solventum Corporation $SOLV - MarketBeat
Solventum Corporation (NYSE:SOLV) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch
Will Solventum's (SOLV) Strong Q4, 2026 Outlook and Buyback Shift Its Capital Allocation Narrative - Sahm
JBC Technologies Named Solventum Premier Converter at MD&M West - Medical Device and Diagnostic industry
Executive equity activity at Solventum Corp (SOLV) as CHRO receives RSUs - Stock Titan
Solventum (NYSE: SOLV) CEO logs 105,963 RSU grant and tax share disposal - Stock Titan
Solventum (SOLV) legal chief gets 14,835 RSUs, covers taxes in shares - Stock Titan
Solventum Corp. stock falls Monday, underperforms market - MarketWatch
Solventum (SOLV) Tops Q1 Earnings and Revenue Estimates - MSN
Solventum’s Post-Spin Discount Looks Big, But Growth Must Show Up - Finimize
Solventum (NYSE:SOLV) Cut to Hold at Wall Street Zen - MarketBeat
A Look At Solventum (SOLV) Valuation After Q4 2025 Earnings Beat And 2026 Outlook Update - simplywall.st
Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), BillionToOne, Inc. Class A (BLLN) and Solventum Corporation (SOLV) - The Globe and Mail
Solventum outlines 2026 organic sales growth of 2%-3% while advancing portfolio optimization and margin expansion - MSN
Solventum (SOLV) Q4 2025 Adjusted Diluted EPS Reaches $1.57 on 3.5% Organic Sales Growth - Finviz
Solventum (SOLV) is Among the Highest-Rated Value Stocks: Is It Worth Purchasing? - Bitget
SOLV Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Commit To Purchase Solventum At $65, Earn 11.6% Annualized Using Options - Nasdaq
Solventum : Shareholder Letter Q4 2025 - marketscreener.com
Solventum Stock: Improvements Come Slow (NYSE:SOLV) - Seeking Alpha
Solventum Corp Stock (SOLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.23%
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):